Inivata Appoints Chair
This article was originally published in Scrip
Executive Summary
Inivata Ltd., a cancer genomics company, has appointed Jeffrey Buchalter non-executive director and chair of its board. Most recently, Buchalter was CEO of Archimedes Pharma Ltd. and also received an award from the American Cancer Society for his commitment to cancer control and involvement in the oncology field. Buchalter has also been collaborating partner in the President's National Dialogue on Cancer and acted as chair of the board at National Childhood Cancer Foundation in the US.